Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Characteristics and prevalence of the metabolic syndrome among three ethnic groups in Canada

Abstract

Objective:

To compare the characteristics and prevalence of the metabolic syndrome (MetS) among Native Indians, Inuit, and non-Aboriginal Canadians.

Methods:

The study was based on four cross-sectional studies conducted in the late 1980s and early 1990s involving three ethnic groups living in contiguous regions in central Canada: Oji-Cree Indians from several reserves in northern Ontario and Manitoba, Inuit from the Keewatin region of the Northwest Territories, and non-Aboriginal Canadians (predominantly of European heritage) in the province of Manitoba. The MetS was identified among adult subjects according to the National Cholesterol Education Program (NCEP) definition. Prevalence rates were standardized to the 1991 Canadian national population.

Results:

The age-standardized prevalence of the MetS varied by ethnic group, ranging from as high as 45% among Native Indian women to as low as 8% among Inuit men. Compared with Canadians of European origin, Indians had a worse metabolic profile, while Inuit had a better metabolic profile except for a high rate of abdominal obesity. The NCEP criteria in identifying individuals with the MetS were compared to those of the World Health Organization (WHO) in a subset of subjects with the requisite laboratory data. There was moderate agreement between the NCEP and WHO definitions, with a kappa value of 0.63 (95% confidence interval 0.56–0.70).

Conclusions:

The results indicate that the MetS is prevalent in diverse ethnic groups in Canada but varies in the pattern of phenotypic expression. Given the diverse nature of these populations, careful consideration should be given to developing culturally appropriate community-based prevention strategies aimed at reducing the frequency of this syndrome.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Reaven GM . Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–1607.

    Article  CAS  PubMed  Google Scholar 

  2. Defronzo RA, Ferrannini E . Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173–193.

    Article  CAS  PubMed  Google Scholar 

  3. Ferrannini E, Haffner SM, Mitchell BD, Stern MP . Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991; 34: 416–422.

    Article  CAS  PubMed  Google Scholar 

  4. Stern MP . Diabetes and cardiovascular disease: the common soil hypothesis. Diabetes 1995; 44: 369–374.

    Article  CAS  PubMed  Google Scholar 

  5. Liese AD, Mayer-Davis EJ, Haffner SM . Development of the multiple metabolic syndrome: an epidemiologic perspective. Epidemiol Rev 1998; 20: 157–172.

    Article  CAS  PubMed  Google Scholar 

  6. Meigs JB . Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors (review). Am J Epidemiol 2000; 152: 908–911.

    Article  CAS  PubMed  Google Scholar 

  7. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683–689.

    Article  CAS  PubMed  Google Scholar 

  8. Lorenzo C, Okoloise SEM, Williams K, Stern MP, Haffner SM . The metabolic syndrome as predictor of type 2 diabetes. Diabetes Care 2003; 26: 3151–3159.

    Article  Google Scholar 

  9. Young TK, Reading J, Elias B, O'Neil JD . Type 2 diabetes mellitus in Canada's first nations: status of an epidemic in progress. CMAJ 2000; 163: 561–566.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Trovato F . Mortality differentials in Canada, 1951–1971: French, British, and Indians. Cult Med Psychiatry 1988; 12: 459–477.

    Article  CAS  PubMed  Google Scholar 

  11. Young TK, Michael E, Moffatt K, O'Neil JD . Cardiovascular diseases in a Canadian arctic population. Am J Public Health 1993; 83: 881–887.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Harris SB, Gittelsohn J, Hanley A, Barnie A, Wolever TM, Gao J et al. The prevalence of NIDDM and associated risk factors in Native Canadians. Diabetes Care 1997; 20: 185–187.

    Article  CAS  PubMed  Google Scholar 

  13. Shah BR, Hux JE, Zinman B . Increasing rates of ischemic heart disease in the native population of Ontario, Canada, Arch. Intern Med 2000; 160: 1862–1866.

    CAS  Google Scholar 

  14. Alberti KG, Zimmet PZ . Definition, diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetes Med 1998; 15: 539–553.

    Article  CAS  Google Scholar 

  15. WHO. Definition, diagnosis and classification of diabetes mellitus and its complications, part 1: diagnosis and classification of diabetes mellitus. Report of a WHO Consultation 1999.

  16. National Cholesterol Education Program. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497.

  17. Grundy SM, Brewer HB, Cleeman JI, Snith SC, Lenfant C . Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433–438.

    Article  PubMed  Google Scholar 

  18. Ford ES, Giles WH, Dietz WH . Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356–360.

    Article  PubMed  Google Scholar 

  19. Resnick HE . Metabolic syndrome in American Indians. Diabetes Care 2002; 25: 1246–1247.

    Article  PubMed  Google Scholar 

  20. Meigs JB, Wilson PWF, Nathan DM, D'Agostino RB, Williams K, Haffner SM . Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes 2003; 52: 2160–2167.

    Article  CAS  PubMed  Google Scholar 

  21. Aguilar-Salinas CA, Rojas R, Gomez-Perez FG, Valles V, Rios-Torres JM, Franco A et al. Analysis of the agreement between the World Health Organization criteria and the National Cholesterol Education Program-III definition of the metabolic syndrome: results from a population-based survey. Diabetes Care 2003; 26: 1635.

    Article  PubMed  Google Scholar 

  22. Ford ES, Giles WH . A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 2003; 26: 575–581.

    Article  PubMed  Google Scholar 

  23. Park YW, Zhu SK, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB . The metabolic syndrome prevalence and associated risk factor findings in the US population from the third national health and nutrition examination survey, 1988–1994. Arch Intern Med 2003; 163: 427–436.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Al-Lawati JA, Mohammed AJ, Al-Hinai HQ, Jousilahti P . Prevalence of the metabolic syndrome among Omani adults. Diabetes Care 2003; 26: 1781–1785.

    Article  PubMed  Google Scholar 

  25. Azizi F, Salehi P, Etemadi A, Zahedi-Asl S . Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract 2003; 61: 29–37.

    Article  PubMed  Google Scholar 

  26. Ardern CI, Katzmarzyk PT, Janssen I, Ross R . Discrimination of health risk by combined body mass index and waist circumference. Obes Res 2003; 11: 135–142.

    Article  PubMed  Google Scholar 

  27. Anand SS, Yi Q, Gerstein H, Lonn E, Jacobs R, Vuksan V et al. Relationship of metabolic syndrome and fibrinolystic dysfunction to cardiovascular disease. Circulation 2003; 108: 420–425.

    Article  CAS  PubMed  Google Scholar 

  28. Jaber LA, Brown MB, Hammad A, Zhu Q, Herman WH . The prevalence of the metabolic syndrome among Arab Americans. Diab Care 2004; 27: 234–238.

    Article  Google Scholar 

  29. Lee WY, Park JS, Noh SY, Rhee EJ, Kim SW, Zimmet PZ . Prevalence of the metabolic syndrome among 40,698 Korean metropolitan subjects. Diab Res Clin Pract 2004; 65: 143–149.

    Article  Google Scholar 

  30. Panagiotakos DB, Pitsavos C, Chrysohoou C, Skoumas J, Tousoulis D, Toutouza M et al. Impact of lifestyle habits on the prevalence of the metabolic syndrome among Greek adults from the ATTICA study. Am Heart J 2004; 147: 106–112.

    Article  PubMed  Google Scholar 

  31. Jørgensen ME, Bjerregaard P, Gyntelberg F, Borch-Johnsen K, the Greenland Population Study. Prevalence of the metabolic syndrome among the Inuit in Greenland. A comparison between two proposed definitions. Diab Med 2004; 21: 1237–1242.

    Article  Google Scholar 

  32. Young TK, Chateau D, Zhang M . Factor analysis of ethnic variation in the multiple metabolic (Insulin Resistance) syndrome in three Canadian populations. Am J Hum Biol 2002; 14: 649–658.

    Article  Google Scholar 

  33. Young TK, Sevenhuysen G . Obesity among northern Indians: patterns, determinants and consequences. Am J Clin Nutr 1989; 49: 786–793.

    Article  CAS  PubMed  Google Scholar 

  34. Young TK . Prevalence and correlates of hypertension in a subarctic Indian population. Prev Med 1991; 20: 474–485.

    Article  CAS  PubMed  Google Scholar 

  35. Gelskey DE, Young TK, Macdonald SM . Screening with total cholesterol: determining sensitivity and specificity of the National Cholesterol Education Program's guidelines from a population survey. J Clin Epidemiol 1994; 47: 547–553.

    Article  CAS  PubMed  Google Scholar 

  36. Young TK, Gelskey DE . Is non-central obesity metabolically benign? Implications for prevention from a population survey of Canadians. JAMA 1995; 274: 1939–1941.

    Article  CAS  PubMed  Google Scholar 

  37. Young TK . Sociocultural and behavioural determinants of obesity among Inuit in the central Canadian Arctic. Soc Sci Med 1996; 43: 1665–1671.

    Article  CAS  PubMed  Google Scholar 

  38. Hanley AJG, Harris SB, Barnie A, Gittelsohn J, Wolever TM, Logan A et al. The Sandy Lake Health and Diabetes Project: design, methods and lessons learned. Chronic Dis Canda 1995; 16: 149–156.

    Google Scholar 

  39. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419.

    Article  CAS  PubMed  Google Scholar 

  40. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation on Obesity. WHO: Geneva, 2000.

  41. Statistics Canada. 2001 Census Aboriginal peoples of Canada: a demographic profile. Cat 96F0030XIE2001007.

  42. Statistics Canada. Profile of census metropolitan areas and census agglomerations (1991 census). Part A and Part B. Ottawa, 1992 and 1993; Cat 93-337 and 93-338.

  43. Grundy SM . Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation 2002; 105: 2696–2698.

    Article  PubMed  Google Scholar 

  44. Okosun IS, Liao Y, Rotimi CN, Prewitt TE, Cooper RS . Abdominal adiposity and clustering of multiple metabolic syndrome in White, Black and Hispanic Americans. Ann Epidemiol 2000; 10: 263–270.

    Article  CAS  PubMed  Google Scholar 

  45. Haffner SM, D'Agostino Jr R, Saad MF, Rewers M, Mykkanen L, Selby J et al. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites: the insulin resistance atherosclerosis study. Diabetes 1996; 45: 742–748.

    Article  CAS  PubMed  Google Scholar 

  46. Hegele RA . Lessons from genetic studies in Native Canadian populations. Nutr Rev 1999; 57: S43–S50.

    Article  CAS  PubMed  Google Scholar 

  47. Young TK, Szathmary E, Evers S, Wheatley B . Geographical distribution of diabetes among the native population of Canada: a national survey. Soc Sci Med 1990; 31: 129–139.

    Article  CAS  PubMed  Google Scholar 

  48. Young TK . Obesity, central fat patterning and their metabolic correlated among the Inuit of the central arctic. Hum Biol 1996; 68: 245–263.

    CAS  PubMed  Google Scholar 

  49. Gittelsohn J, Wolever TM, Harris SB, Harris-Giraldo R, Hanley AJ, Zinman B . Specific patterns of food consumption and preparation are associated with diabetes and obesity in a native Canadian community. J Nutr 1998; 128: 541–547.

    Article  CAS  PubMed  Google Scholar 

  50. Bjerregaard P, Jørgensen ME, Borch-Johnsen K . Serum lipids of Greenland Inuit in relation to Inuit genetic heritage, westernization and migration. Atherosclerosis 2004; 174: 391–398.

    Article  CAS  PubMed  Google Scholar 

  51. Dewailly E, Blanchet C, Gingras S, Lemieux S, Holub BJ . Cardiovascular disease risk factors and n-3 fatty acid status in the adult population of James Bay Cree. Am J Clin Nutri 2002; 76: 85–92.

    Article  CAS  Google Scholar 

  52. Dewailly E, Blanchet C, Lemieux S, Sauvé L, Gingras S, Ayotte P et al. n_3 Fatty acids and cardiovascular disease risk factors among the Inuit of Nunavik. Am J Clin Nutr 2001; 74: 464–473.

    Article  CAS  PubMed  Google Scholar 

  53. Bjerregaard P, Jørgensen ME, Andersen S, Mulvad G, Borch-Johnsen K, The Greenland Population Study. Decreasing overweight and central fat patterning with Westernization among the Inuit in Greenland and Inuit migrants. Int J Obes Relat Metab Disord 2002; 26: 1503–1510.

    Article  CAS  PubMed  Google Scholar 

  54. Green C, Blanchard J, Young TK, Griffith J . The epidemiology of diabetes in the Manitoba-registered First Nation population: current patterns and comparative trends. Diabetes Care 2003; 26: 1993–1998.

    Article  PubMed  Google Scholar 

  55. Gittelsohn J, Harris SB, Whitehehad S, Wolever TM, Hanley A, Barnie A et al. Developing diabetes interventions in an Ojibwa-Cree community in northern Ontario: linking qualitative and quantitative data. Chronic Dis Can 1995; 16: 157–164.

    Google Scholar 

  56. Macaulay AC, Harris SB, Lévesque L, Cargo M, Ford E, Salsberg J et al. Primary prevention of type 2 diabetes: experience of 2 Aboriginal communities in Canada. Can J Diabetes 2003; 27: 464–475.

    Google Scholar 

Download references

Acknowledgements

We acknowledge the study participants and leadership of each of the participating communities. Ms Liu is supported by the Canadian Institutes for Health Research (CIHR) through a Canada Graduate Scholarships Masters Award. Dr Hanley is a Scholar of the Canadian Diabetes Association and a Banting and Best Diabetes Centre New Investigator. Dr Young is a Senior Investigator of the CIHR and the TransCanada Pipelines Chair in Aboriginal Health. Dr Harris is the Ian McWhinney Chair for Studies in Family Medicine. Dr Zinman holds The Sam and Judy Pencer Family Chair in Diabetes Research at Mount Sinai Hospital.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T K Young.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, J., Hanley, A., Young, T. et al. Characteristics and prevalence of the metabolic syndrome among three ethnic groups in Canada. Int J Obes 30, 669–676 (2006). https://doi.org/10.1038/sj.ijo.0803179

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijo.0803179

Keywords

This article is cited by

Search

Quick links